Gilead Sciences CFO Sells Shares Amid Positive Earnings and Strategic Updates
Despite the recent sale of shares by Chief Financial Officer Andrew D. Dickinson, Gilead Sciences Inc. (NASDAQ:GILD) continues to demonstrate strong operational momentum. The company reported first-quarter 2026 earnings that surpassed market expectations, leading to updated revenue guidance and strategic financial moves.